| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945189 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
As a single agent, CPT-11 has anti-tumor activity for advanced or recurrent endometrial cancer and has manageable adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Shin Nishio, Mototsugu Shimokawa, Kazuto Tasaki, Hiroki Nasu, Teruyuki Yoshimitsu, Ken Matsukuma, Atsumu Terada, Naotake Tsuda, Kouichiro Kawano, Kimio Ushijima,